INVESTOR RELATIONS

OVERVIEW

MagPlasma develops plasma-based technologies that replace conventional heat and chemical processes with cleaner, faster, energy-efficient plasma systems.

From air purification and sterilization to material activation and regeneration, our solutions deliver high-performance results with a fraction of the energy and environmental impact.

Headquartered in Michigan, MagPlasma bridges advanced research with practical, commercial applications that support safer, more sustainable industries.

WHY INVEST IN MAGPLASMA

  • Proven Results: Our BZAP® system achieves up to 99.9999% reduction in airborne pathogens in a single pass.
  • Scalable Technology: The same plasma foundation powers solutions for air, surface, and material treatment and scales easily from portable solutions to larger processes and installations.
  • Sustainability Edge: Processes use watts—not kilowatts—of energy without the need for routine maintenance or expensive consumables.
  • Growing Market Demand: Contagion clean air, surface sterilization, and regenerative material solutions are expanding across health, manufacturing, and energy sectors. Proven market need and field demonstrations for law enforcement, Customs and Border Protection, and emergency medical response.
  • Strong IP Pipeline: Issued and pending patents and trademark provide strong intellectual property protection for MagPlasma products.

RECENT MILESTONES

  • Launched the BZAP® Breathing Zone Air Sterilizer line.
  • Developed the Plasma Autoclave — a dry, low pressure sterilization system for sensitive materials, optics, and electronics.
  • Demonstrated rapid sorbent regeneration using low-energy plasma activation.
  • Expanded strategic partnerships across research and industrial manufacturing sectors.

INVESTMENT OPPORTUNITIES

MagPlasma is currently engaging early-stage investors to accelerate commercialization, expand testing capacity, and scale manufacturing.

Funding supports:

  • Pilot production and product certification.
  • Begin product sales.
  • Continued R&D and IP protection.
  • Strategic market entry and partnerships.
  • Team growth and operational expansion.

CONNECT WITH US

For investor materials or to request a private briefing: